Financial Ratios

TRINITY BIO-TECH LTD.

NSE : NABSE : 530573ISIN CODE : INE785B01016Industry : Finance - NBFCHouse : Private
BSE3.600 (0 %)
PREV CLOSE ( ) 3.60
OPEN PRICE ( ) 3.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )3.60 3.60
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)0.07-0.040.40-1.870.03
   CEPS(Rs)0.07-0.040.40-1.870.03
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-6.74-6.81-6.77-7.17-5.31
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)57.38-76.5156.57118.55
   EBIT Margin(%)57.38-75.9656.57118.55
   Pre Tax Margin(%)57.33-75.9856.49119.02
   PAT Margin (%)57.33-75.9856.49119.02
   Cash Profit Margin (%)57.33-75.9856.49119.02
Performance Ratios
   ROA(%)0.36-0.212.17-8.170.12
   ROE(%)0.000.000.000.000.00
   ROCE(%)0.36-0.222.19-8.200.12
   Asset Turnover(x)0.010.000.04-0.070.00
   Sales/Fixed Asset(x)5.352.4332.70-72.10
   Working Capital/Sales(x)0.500.173.11-7.210.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.190.410.03-0.01
   Receivable days0.000.000.000.00
   Inventory Days0.000.000.000.00
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)303.21667.5649.62-22.50
   EV/Core EBITDA(x)528.43-878.8187.71-18.981247.92
   EV/EBIT(x)528.43-878.8187.71-18.981247.92
   EV/CE(x)1.881.891.891.931.54
   M Cap / Sales0.000.000.000.00
Growth Ratio
   Net Sales Growth(%)120.57-92.58-145.35
   Core EBITDA Growth(%)266.61-109.96121.64-5583.61174.93
   EBIT Growth(%)266.61-109.96121.64-5583.61174.93
   PAT Growth(%)266.44-109.98121.52-5605.37148.75
   EPS Growth(%)266.44-109.98121.52-5605.37148.75
Financial Stability Ratios
   Total Debt/Equity(x)-3.76-3.72-3.75-3.54-6.13
   Current Ratio(x)19.2324.7219.0118.11103.54
   Quick Ratio(x)19.2324.7219.0118.11103.54
   Interest Cover(x)1241.39-4763.25705.90-251.93
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.